Title: A  Study on Clinico-Aetiological Profile of Acanthosis Nigricans in a Rural Medical College

Authors: AJS Pravin, Ahammed Sadik

 DOI: https://dx.doi.org/10.18535/jmscr/v8i2.100

Abstract

   

Introduction

Acanthosis Nigricans is characterised by darkening (hyper pigmentation) and thickening (hyperkeratosis) of the skin, occurring mainly in the folds of the skin in the armpit (axilla), groin and back of the neck. It can occur with endocrine diseases such as diabetes mellitus, thyroid disorders, Cushing disease, PCOD, underlying malignancies, certain drugs, and as a genetic disorder. It is most common in people who have insulin resistance those whose body is not responding correctly to the insulin that they make in their pancreas. It is not a skin disease per se but a cutaneous sign of an underlying disorder.

Neck is the most commonly affected area. More than ninety percent of peoples AN have neck involvement. Axilla is the second most common area involved. There are two important types of acanthosis nigricans: benign and malignant. Although it is classically described as a sign of internal malignancy, this is very rare. Benign types, sometimes described as ‘pseudoacanthosis nigricans’ are much more common which is related to obesity. AN is common in some populations and its prevalence changes with different races and is more prevalent in people with darker skin pigmentation.

Acanthosis nigricans (AN) is a dermatosis characterized by velvety, papillomatous, brownish-black, hyperkeratotic plaques, typically appears on the intertriginous areas and neck. A although it may be associated with  internal malignancy, it is more common with obesity and insulin resistance and hence allows for diagnosis of related disorders including type 2 diabetes, the metabolic syndrome, and polycystic ovary syndrome in asymptomatic cases also. Early recognition of these conditions is very helpful for prevention of disease progression and related complications. The exact incidence of acanthosis nigricans is unknown. In a study of unselected population of 1412 children, the changes of AN were present in 7.1%.

References

  1. Fine RM. Acanthosis nigricans. Int J Dermatol.
  2. Brown J, Winkelmann RK. Acanthosis nigricans: A study of 90 cases. Medicine (Baltimore)
  3. Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: A common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol.
  4. Grasinger CC, Wild RA, Parker IJ. Vulvar achanthosis nigricans: A marker for insulin resistance in hirsute women. FertilSteril.
  5. Curth HO. Acanthosis nigricans: birth defects. Orig Art Ser.
  6. Annos T, Taymor ML. Ovarian pathology associated with insulin resistance and acanthosis nigricans. Obstet Gynecol.
  7. Conway GS, Jacobs HS. Clinical implications of hyperinsulinemia in women. Clin Endocrinol (Oxf) 12. Higgins SP, Freemark M, Prose NS. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J.
  8. Imperato-McGinley J, Peterson RE, Sturla E, Dawood Y, Bar RS. Primary amenorrhea, associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance. Am J Med.
  9. Flier JS, Fastman RC, Minakes KL, Matteson D, Rowe JW. Acanthosis nigricans in obese women with hyperandrogenism: Characterization of an insulin-resistant state distinct from the type A and B syndromes. Diabetes. 1985;34:101–7. [PubMed: 3881301]
  10. Hud JA, Cohen JB, Wagner JM, Cruz PD. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol. 1992;128:941–4. [PubMed: 1626961].

Corresponding Author

AJS Pravin

Professor and HOD, Department of Dermatology, KGMCH, Asaripallam